Aspen Aerogels (NYSE:ASPN) Price Target Cut to $16.00 by Analysts at Roth Mkm

Aspen Aerogels (NYSE:ASPN) had its price target trimmed by Roth Mkm from $22.00 to $16.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the construction company’s stock.

Several other brokerages have also recently issued reports on ASPN. Seaport Res Ptn cut Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Barclays cut their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Finally, Canaccord Genuity Group cut their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus target price of $24.67.

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $8.67 on Friday. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15. The stock’s 50 day moving average is $12.27 and its 200-day moving average is $18.56. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $711.02 million, a price-to-earnings ratio of 867.47 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Equities research analysts expect that Aspen Aerogels will post 0.12 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPN. AlphaQuest LLC increased its holdings in shares of Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after buying an additional 3,998 shares in the last quarter. nVerses Capital LLC increased its holdings in shares of Aspen Aerogels by 45.0% during the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Aspen Aerogels during the fourth quarter worth $164,000. Connors Investor Services Inc. acquired a new position in shares of Aspen Aerogels during the fourth quarter worth $168,000. Finally, Journey Strategic Wealth LLC acquired a new position in shares of Aspen Aerogels during the fourth quarter worth $178,000. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.